STOCK TITAN

Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Syndax Pharmaceuticals (SNDX) CEO to participate in fireside chat at Stifel 2024 Virtual Targeted Oncology Forum. The event will be held on April 17, 2024, at 11:00 a.m. ET. Investors can access the live webcast on the company's website.
Positive
  • None.
Negative
  • None.

WALTHAM, Mass., April 10, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, will participate in a fireside chat at the at Stifel 2024 Virtual Targeted Oncology Forum on Wednesday, April 17, 2024, at 11:00 a.m. ET.

A live webcast of the fireside chat can be accessed from the Investor section of the Company's website at www.syndax.com, where a replay of the event will also be available for a limited time.

About Syndax

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include revumenib, a highly selective inhibitor of the menin–KMT2A binding interaction, and axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. For more information, please visit. For more information, please visit www.syndax.com or follow the Company on X (formerly Twitter) and LinkedIn.

Syndax Contact

Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827

SNDX-G

Cision View original content:https://www.prnewswire.com/news-releases/syndax-announces-participation-at-the-stifel-2024-virtual-targeted-oncology-forum-302113234.html

SOURCE Syndax Pharmaceuticals, Inc.

Michael A. Metzger, CEO of Syndax Pharmaceuticals, will participate in the fireside chat on Wednesday, April 17, 2024, at 11:00 a.m. ET.

Investors can access the live webcast on the Investor section of Syndax Pharmaceuticals' website at www.syndax.com.

Yes, a replay of the event will also be available on the Company's website for a time.

The ticker symbol for Syndax Pharmaceuticals is SNDX.
Syndax Pharmaceuticals, Inc.

NASDAQ:SNDX

SNDX Rankings

SNDX Latest News

SNDX Stock Data

1.81B
84.63M
0.82%
106.63%
11.32%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
WALTHAM

About SNDX

syndax pharmaceuticals is a biotechnology company located at 35 gatehouse dr., building d, floor 3, waltham, ma 02451.